Insurance Business was Bgm’s largest segment in fiscal 2025, bringing in $10.96M of $14.33M (77%).
| Segment | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|
| Diversified Pharmaceutical & Allied Products | — | $46.47M | $25.10M | — | ||||
| Oxytetracycline Licorice Products & Tcmd | $40.31M | — | — | — | ||||
| Heparin Products & Sausage Casing | $23.46M | — | — | — | ||||
| Insurance Business | — | — | — | $10.96M | ||||
| Ai Solutions | — | — | — | $3.36M | ||||
| Fertilizer | $1.09M | — | — | — | ||||
| Total | $64.86M | $46.47M | $25.10M | $14.33M |
Bgm brought in $14.33M from its two segments in fiscal 2025, the year ended September 30, 2025. Bgm regrouped these segments after fiscal 2024, so the total does not compare directly with that year's $25.10M. Insurance Business was the largest at $10.96M (76.5%), ahead of Ai Solutions at $3.36M (23.5%).
Bgm began breaking out Insurance Business in fiscal 2025 and Ai Solutions in fiscal 2025. Bgm stopped reporting Oxytetracycline Licorice Products & Tcmd ($40.31M in fiscal 2022), Diversified Pharmaceutical & Allied Products ($25.10M in fiscal 2024), Heparin Products & Sausage Casing ($23.46M in fiscal 2022) and one other as separate segments.
Bgm (BGM) reports its revenue by segment. In fiscal 2025, Insurance Business was its largest segment, bringing in $10.96M (76.5% of the total), followed by Ai Solutions at $3.36M (23.5%).
Insurance Business was Bgm's largest segment in fiscal 2025, bringing in $10.96M, or 76.5% of the $14.33M total across its two segments.
Every figure comes from Bgm's annual financial filings, as reported. Each line keeps the name Bgm gives it, and years follow its fiscal calendar.
Bgm's revenue by segment goes back to fiscal 2018, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.